Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels. [electronic resource]
- Arteriosclerosis, thrombosis, and vascular biology Sep 2013
- 2121-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4636
10.1161/ATVBAHA.113.001974 doi
Animals Anti-Inflammatory Agents--pharmacology Atrial Natriuretic Factor--pharmacology Calcium--metabolism Calcium Channel Blockers--pharmacology Capillary Permeability--drug effects Cyclic GMP-Dependent Protein Kinase Type I--deficiency Dose-Response Relationship, Drug Endothelial Cells--drug effects HEK293 Cells Histamine--pharmacology Histamine Antagonists--pharmacology Human Umbilical Vein Endothelial Cells--drug effects Humans Male Mast Cells--drug effects Membrane Proteins Mice Mice, Knockout Microvessels--drug effects Phosphodiesterase 5 Inhibitors--pharmacology Phosphoproteins--genetics Phosphorylation Receptors, Atrial Natriuretic Factor--genetics Signal Transduction--drug effects TRPC Cation Channels--deficiency TRPC6 Cation Channel Time Factors Transfection